Organigram Global Q2 Earnings Call Highlights
Key Points - Organigram Global posted weaker fiscal Q2 2026 results, with net revenue down about 9% year over year to CAD 59.8 million and adjusted EBITDA falling to CAD 0.9 million. Management blamed operational issues in vapes and infused pre-rolls, softer Canadian marke